2021. RFLSP.Russian.Finnish.Life.Science.Industry.EN

2.21 FARMAMED.RF
Company profile
The Russian company Farmamed.RF produces finished medicines
and pharmaceutical substances. The company conducts research
on the basis of its own laboratory in the synthesis of new
medicines and search for new dosage forms. In April 2015,
Farmamed.RF successfully passed the state certification of
pharmaceutical production under the international GMP
standard.
Farmamed.RF is one of the few Russian companies producing full
synthesis of high quality active pharmaceutical substances. The
company is licensed to produce pharmaceutical substances by
methods of isolation from sources of chemical, biological, animal
and plant origin and by methods of biotechnological and chemical
synthesis. The company has received numerous awards for high
quality performance in its professional activities.
Products and services
The company produces finished forms and number of
pharmaceutical substances, including the following types:
§ Emoxypine;
§ Unithiol;
§ Meldonium;
§ Methylaethylpiridinolum hydrochloride.
Key figures:
Founded: 26.11.2002
Turnover (2020): 530,895 mln. RUB
Employees (2020): -
INN: 7802201882
Type of company: small enterprise
Product code: 21.20.1 Manufacturing of
pharmaceuticals
Contact information:
Domostroitelnaia Str., 16 lit. E premises 2
194292 St. Petersburg, Russia
+7 (812) 647 02 46
+7 (812) 596 34 28
info@farmamedspb.ru
https://farmamedspb.ru/
Contact person: Gomzhin Andrei – General
director
RUSSIAN-FINNISH LIFE SCIENCE INDUSTRY
Research and export directory
109